Clinical Trials

Showing trials with last updates posted in 2025.

NCT04794322 | RECRUITING
250 participants

Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer

Study Type:
OBSERVATIONAL
Last Updated:
2025-09-16
Start Date:
2020-04-13
Completion:
2027-08-31
Conditions
  • Ovarian Neoplasms
  • Ovarian Epithelial Carcinoma
  • Fallopian Tube Neoplasms
  • High Grade Ovarian Serous Adenocarcinoma
  • Stage I Ovarian Cancer
  • Stage II Ovarian Cancer
  • Stage III Ovarian Cancer AJCC v8
  • Stage IIIA Ovarian Cancer AJCC v8
  • Stage IIIA1 Ovarian Cancer AJCC v8
  • Stage IIIA2 Ovarian Cancer AJCC v8
  • Stage IIIB Ovarian Cancer AJCC v8
  • Stage IIIC Ovarian Cancer AJCC v8
  • Stage IV Ovarian Cancer AJCC v8
  • Stage IVA Ovarian Cancer AJCC v8
  • Stage IVB Ovarian Cancer AJCC v8
Interventions
  • DIAGNOSTIC_TEST
No Results Yet
NCT04759274 | RECRUITING | NA
30 participants

Diuretic Tuner Clinical Decision Support

Study Type:
INTERVENTIONAL
Last Updated:
2025-09-16
Start Date:
2023-11-20
Completion:
2026-08-31
Conditions
  • Edema
  • Hypervolemia
  • Chronic Kidney Diseases
  • Nephrotic Syndrome
Interventions
  • DEVICE
No Results Yet
NCT04655508 | TERMINATED | PHASE3
35 participants

Efficacy of Fluticasone Propionate Associated With Salmeterol Using Inhalation Chamber Versus Placebo to Improve the Respiratory Function in Children Over Six Years of Age Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation With a Decline of FEV1 ≥10% From Pre Transplantation

Study Type:
INTERVENTIONAL
Last Updated:
2025-09-16
Start Date:
2021-05-21
Completion:
2023-09-27
Conditions
  • Stem Cell Transplant Complications
  • Respiratory Disease
  • Bronchiolitis Obliterans
Interventions
  • DRUG
No Results Yet
NCT04609839 | WITHDRAWN
0 participants

FOLLOW-UP OF PATIENTS WITH COVID-19.

Study Type:
OBSERVATIONAL
Last Updated:
2025-09-16
Start Date:
2020-09-15
Completion:
2023-10-17
Conditions
  • Patient Admitted to Intensive Care Unit for COVID-19
Interventions
  • OTHER
No Results Yet
NCT04249622 | TERMINATED | PHASE2
20 participants

Rifaximin for the Treatment of Gastrointestinal Toxicities Related to Pertuzumab-Based Therapy in Patients With Stage I-III HER2 Positive Breast Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2025-09-16
Start Date:
2020-09-18
Completion:
2022-12-27
Conditions
  • Anatomic Stage I Breast Cancer AJCC v8
  • Anatomic Stage IA Breast Cancer AJCC v8
  • Anatomic Stage IB Breast Cancer AJCC v8
  • Anatomic Stage II Breast Cancer AJCC v8
  • Anatomic Stage IIA Breast Cancer AJCC v8
  • Anatomic Stage IIB Breast Cancer AJCC v8
  • Anatomic Stage III Breast Cancer AJCC v8
  • Anatomic Stage IIIA Breast Cancer AJCC v8
  • Anatomic Stage IIIB Breast Cancer AJCC v8
  • Anatomic Stage IIIC Breast Cancer AJCC v8
  • HER2 Positive Breast Carcinoma
  • Prognostic Stage I Breast Cancer AJCC v8
  • Prognostic Stage IA Breast Cancer AJCC v8
  • Prognostic Stage IB Breast Cancer AJCC v8
  • Prognostic Stage II Breast Cancer AJCC v8
  • Prognostic Stage IIA Breast Cancer AJCC v8
  • Prognostic Stage IIB Breast Cancer AJCC v8
  • Prognostic Stage III Breast Cancer AJCC v8
  • Prognostic Stage IIIA Breast Cancer AJCC v8
  • Prognostic Stage IIIB Breast Cancer AJCC v8
  • Prognostic Stage IIIC Breast Cancer AJCC v8
Interventions
  • OTHER
  • DRUG
Previous
Sorted by latest updates
Next
Showing 40 trials per page